Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study

References

• European Respiratory SocietyEuropean Lung White BookHudders-fieldEuropean Respiratory Society Journals, Ltd2003
   Google Scholar
• MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med20063e44217132052
   PubMed Web of Science ®Google Scholar
• BuistASMcBurnieMAVollmerWMInternational variation in the prevalence of COPD (the BOLD study): a population-based prevalence studyLancet200737074175017765523
   PubMed Web of Science ®Google Scholar
• Cabrera LopezCJulia SerdaGCabrera LacalzadaCPrevalence of chronic obstructive pulmonary disease in the Canary IslandsArch Bronconeumol20145027227724507558
   PubMed Web of Science ®Google Scholar
• MiravitllesMSorianoJBGarcia-RioFPrevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activitiesThorax20096486386819553233
   PubMed Web of Science ®Google Scholar
• The Global Strategy for the Diagnosis MAPOCOPDGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)2015 Available from: http://www.goldcopd.org/Accessed April 14, 2016
   Google Scholar
• ChavezPCShokarNKDiagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinicCOPD2009644645119938968
   PubMedGoogle Scholar
• PerezXWisniveskyJPLurslurchachaiLBarriers to adherence to COPD guidelines among primary care providersRespir Med201210637438122000501
   PubMed Web of Science ®Google Scholar
• BourbeauJSebaldtRJDayAPractice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE studyCan Respir J200815131918292848
   PubMed Web of Science ®Google Scholar
• LangePRasmussenFVBorgeskovHThe quality of COPD care in general practice in Denmark: the KVASIMODO studyPrim Care Respir J20071617418117516009
   PubMedGoogle Scholar
• LiFCaiYZhuYThe evaluation of general practitioners’ awareness/knowledge and adherence to the GOLD guidelines in a Shanghai SuburbAsia Pac J Public Health2015272NP2067NP207823420058
   PubMed Web of Science ®Google Scholar
• RutschmannOTJanssensJ-PVermeulenBKnowledge of guidelines for the management of COPD: a survey of primary care physiciansRespir Med20049893293715481268
   PubMed Web of Science ®Google Scholar
• MiravitllesMSicrasACrespoCCosts of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care settingTher Adv Respir Dis2013713915023653458
   PubMed Web of Science ®Google Scholar
• AgustiAFabbriLMInhaled steroids in COPD: when should they be used?Lancet Respir Med2014286987125439566
   PubMed Web of Science ®Google Scholar
• ODonnellDEHernandezPKaplanACanadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2008 update – highlights for primary careCan Respir J2008151A
   Web of Science ®Google Scholar
• CelliBRMacNeeWAgustiAStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J20042393215219010
   PubMed Web of Science ®Google Scholar
• BestallJCPaulEAGarrodRUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax19995458158610377201
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J20052631933816055882
   PubMed Web of Science ®Google Scholar
• CastellsaguéJBurgosFSunyerJPrediction equations for forced spirometry from European origin populations. Barcelona Collaborative Group on Reference Values for Pulmonary Function Testing and the Spanish Group of the European Community Respiratory Health SurveyRespir Med1998924014079692096
   PubMed Web of Science ®Google Scholar
• BilderCRZhangBSchaarschmidtFbinGroup: a package for group testingR J20102566021833347
   PubMedGoogle Scholar
• NishimuraKIzumiTTsukinoMDyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPDChest20021211434144012006425
   PubMed Web of Science ®Google Scholar
• AlmagroPMartinez-CamblorPSorianoJBFinding the best thresholds of FEV1 and dyspnea to predict 5-year survival in COPD patients: the COCOMICS studyPLoS One20149e8986624587085
   PubMed Web of Science ®Google Scholar
• CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350100514999112
   PubMed Web of Science ®Google Scholar
• CasanovaCAguirre-JaimeAde TorresJPLongitudinal assessment in COPD patients: multidimensional variability and outcomesEur Respir J20144374575324072210
   PubMed Web of Science ®Google Scholar
• CasanovaCde TorresJPAguirre-JaimeAThe progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohortAm J Respir Crit Care Med20111841015102121836135
   PubMed Web of Science ®Google Scholar
• LangePCelliBAgustíALung-function trajectories leading to chronic obstructive pulmonary diseaseN Engl J Med201537311112226154786
   PubMed Web of Science ®Google Scholar
• D’UrzoADDe SalvoMCRamirez-RiveraAIn patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium: a 3-week, randomized, double-blind, within-patient, multicenter studyChest20011191347135611348938
   PubMed Web of Science ®Google Scholar
• van NoordJAAumannJLJanssensEComparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPDEur Respir J20052621422216055868
   PubMed Web of Science ®Google Scholar
• LangePMarottJLVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med201218697598122997207
   PubMed Web of Science ®Google Scholar